Remus Pharmaceuticals Beneish M-Score Historical Data
The historical data trend for Remus Pharmaceuticals's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Remus Pharmaceuticals Beneish M-Score Chart
|
Remus Pharmaceuticals Annual Data
|
|
Trend |
Mar20 |
Mar21 |
Mar22 |
Mar24 |
| Beneish M-Score |
|
- |
- |
-2.73 |
7.97 |
|
Remus Pharmaceuticals Semi-Annual Data
|
|
Mar20 |
Mar21 |
Mar22 |
Sep23 |
Mar24 |
Sep24 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
- |
-2.73 |
- |
7.97 |
- |
Competitive Comparison of Remus Pharmaceuticals's Beneish M-Score
For the Medical Distribution subindustry, Remus Pharmaceuticals's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Remus Pharmaceuticals's Beneish M-Score Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Remus Pharmaceuticals's Beneish M-Score falls into.
Remus Pharmaceuticals Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Remus Pharmaceuticals for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 4.0787 | + | 0.528 * 2.2196 | + | 0.404 * 0.354 | + | 0.892 * 8.5973 | + | 0.115 * 1.1826 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0.3055 | + | 4.679 * 0.06971 | - | 0.327 * 1.0141 |
| = | 7.97 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Mar24) TTM: | Last Year (Mar22) TTM: |
Total Receivables was ₹1,145 Mil.
Revenue was ₹2,125 Mil.
Gross Profit was ₹481 Mil.
Total Current Assets was ₹2,097 Mil.
Total Assets was ₹2,573 Mil.
Property, Plant and Equipment(Net PPE) was ₹23 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹9 Mil.
Selling, General, & Admin. Expense(SGA) was ₹91 Mil.
Total Current Liabilities was ₹1,495 Mil.
Long-Term Debt & Capital Lease Obligation was ₹30 Mil.
Net Income was ₹215 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹36 Mil.
|
Total Receivables was ₹33 Mil.
Revenue was ₹247 Mil.
Gross Profit was ₹124 Mil.
Total Current Assets was ₹77 Mil.
Total Assets was ₹159 Mil.
Property, Plant and Equipment(Net PPE) was ₹3 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹2 Mil.
Selling, General, & Admin. Expense(SGA) was ₹35 Mil.
Total Current Liabilities was ₹92 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (1144.772 / 2124.996) | / | (32.646 / 247.171) |
| = | 0.538717 | / | 0.132079 |
| | = | 4.0787 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (124.269 / 247.171) | / | (481.339 / 2124.996) |
| = | 0.502765 | / | 0.226513 |
| | = | 2.2196 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (2097.396 + 22.751) / 2572.727) | / | (1 - (76.942 + 3.085) / 159.093) |
| = | 0.175915 | / | 0.49698 |
| | = | 0.354 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 2124.996 | / | 247.171 |
| | = | 8.5973 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (1.548 / (1.548 + 3.085)) | / | (8.959 / (8.959 + 22.751)) |
| = | 0.334125 | / | 0.282529 |
| | = | 1.1826 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (91.332 / 2124.996) | / | (34.771 / 247.171) |
| = | 0.04298 | / | 0.140676 |
| | = | 0.3055 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((29.954 + 1494.818) / 2572.727) | / | ((0.986 + 91.99) / 159.093) |
| = | 0.592668 | / | 0.584413 |
| | = | 1.0141 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (215.37 - 0 | - | 36.024) | / | 2572.727 |
| | = | 0.06971 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Remus Pharmaceuticals has a M-score of 7.97 signals that the company is likely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:REMUS has been successfully added to your